Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in high risk diffuse large cell B-cell lymphoma patients as a first line treatment. Issue 7 (2nd July 2016) - Schwarzbich, Mark-Alexander; Schöning, Tilman; Cremer, Martin; Lisenko, Katharina; Ho, Anthony D.; Witzens-Harig, Matthias